Semi-Solid Dosage Contract Manufacturing Market Emerging Trends and Growth Drivers Through 2029 | Reach USD $26.76 Billion
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Semi-Solid Dosage Contract Manufacturing Market Today And What Is Its Future Size?
In recent times, the market size for semi-solid dosage contract manufacturing has seen rapid expansion. The market, which is projected to increase from $16.23 billion in 2024 to $17.97 billion in 2025, will enjoy a compound annual growth rate (CAGR) of 10.7%. The growth witnessed in the previous period can be credited to several factors, including an upswing in the population of the elderly, increased global healthcare spending, a rise in demand for hormone replacement therapies, enhanced awareness of skincare health, and the growth of biologics and biosimilars in topical forms.
Expectations are high for the semi-solid dosage contract manufacturing market as it is predicted to experience accelerated growth in the coming years. The market size is projected to reach $26.76 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.5%. This growth during the projected period is mainly attributed to the surging demand for dermatological treatments, a rise in chronic skin conditions, a boost in generic drug production, cost-effective contract manufacturing, and an increase in the popularity of topical drug delivery. Key trends for this period comprise progress in formulation technologies, the necessity for adaptable manufacturing capacity, the usage of quality-by-design methods, technological improvements in semi-solid processing equipment, and a rising demand for expedited drug development.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25899&type=smp
What External And Internal Drivers Are Influencing The Semi-Solid Dosage Contract Manufacturing Market?
The semi-solid dosage contract manufacturing market’s growth is anticipated to be propelled by the rising occurrence of skin diseases. These ailments, which cause changes to the skin appearance or its functions, often exhibit symptoms such as abnormal skin growths, inflammation, and discomfort. The escalating environmental pollution is largely responsible for an increase in skin diseases, as it weakens the skin’s protective barrier, causing heightened sensitivity, consistent skin issues, and allergic reactions. Through reliable formulation of high-quality topical treatments, contract manufacturing for semi-solid dosage forms aids in preventing skin diseases, and subsequently improving skin health. For example, statistics from Cancer Research UK, a leading cancer research foundation, in February 2023 predict that annual incidences of melanoma skin cancer in the UK will likely rise from nearly 20,800 cases between 2023-2025 to approximately 26,500 cases within 2038-2040. Thus, due to the high rate of skin diseases, the semi-solid dosage contract manufacturing market is witnessing substantial growth.
How Is The Semi-Solid Dosage Contract Manufacturing Market Categorized Across Applications And Types?
The semi-solid dosage contract manufacturing market covered in this report is segmented –
1) By Type: Topical, Transdermal, Oral
2) By Material Type: Synthetic, Natural, Bio-Based
3) By Company Size: Large Size Companies, Medium And Small Size Companies, Other Company Sizes
4) By Therapeutic Application: Dermatology, Pain Management, Hormonal Therapy, Wound Care, Ophthalmic Disorders, Other Therapeutic Applications
5) By End Use: Pharmaceutical Companies, Cosmeceutical Companies, Other End Uses
Subsegments:
1) By Topical: Creams, Ointments, Gels, Lotions, Pastes, Foams
2) By Transdermal: Transdermal Gels, Transdermal Creams, Transdermal Sprays, Transdermal Emulsions, Medicated Patches
3) By Oral: Oral Gels, Oral Pastes, Oral Suspensions, Oral Emulsions, Oral Jellies
How Are Market Trends Influencing Competition In The Semi-Solid Dosage Contract Manufacturing Market?
Key players in the semi-solid dosage contract manufacturing market are making strategic financial moves to foster growth and explore new market opportunities. These investments are aimed at reinforcing a company’s long-term goals, enhancing its market position, and facilitating future expansion. For instance, LGM Pharma, a semi-solid dosage contract manufacturing service provider based in the US, in March 2025, declared an investment of more than $6 million to extend its manufacturing facility in Rosenberg, Texas. This initiative seeks to escalate the production capacity for liquid, suspension, semi-solid, and suppository drug formations in response to the growing demand for local pharmaceutical manufacturing. It is part of LGM Pharma’s continuous efforts to expand in the prescription drug development sector, including 505(b)(2) and ANDA programs. The renovations at the Rosenberg location will enable an increase in production while adhering to FDA regulations and current best manufacturing practices. The facility will maintain uninterrupted operations during the expansion phase.
Who Are The Global Leaders Steering The Semi-Solid Dosage Contract Manufacturing Market Forward?
Major companies operating in the semi-solid dosage contract manufacturing market are Eurofins Scientific SE, The Lubrizol Corporation, Grunenthal, Recipharm AB, Piramal Pharma Solutions Inc., Cambrex Corporation, Sharp Services, ANI Pharmaceuticals, Pierre Fabre SA, Aurigene Pharmaceutical Services Limited, DPT Laboratories Ltd., Douglas Pharmaceuticals Ltd., Mission Pharmacal Co., Pace Analytical Life Sciences LLC, Bora Pharmaceuticals Co. Ltd., Ascendia Pharmaceuticals Inc., Fermion Oy, Ferndale Pharma Group, Sterling Pharmaceutical Services LLC, Aphena Pharma Solutions Inc., Eubioco LLC, LGM Pharma LLC, Madras Pharmaceuticals, Quality CDMO, Axxelent Pharma Science.
Access The Complete Report Here:
What Are The Emerging Regional Trends Driving The Semi-Solid Dosage Contract Manufacturing Market?
North America was the largest region in the semi-solid dosage contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the semi-solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25899&type=smp
Browse Through More Reports Similar to the Global Semi-Solid Dosage Contract Manufacturing Market 2025, By The Business Research Company
Pharmaceutical Continuous Manufacturing Global Market Report 2025
Unit Dose Manufacturing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/unit-dose-manufacturing-global-market-report
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Global Market Report 2025
About The Business Research Company:
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
